56 employees
Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. Show more Show less
$81M sweet spot round size
2020
$81M
from 3 investors over 1 rounds
Evozyne raised $81M on October 27, 2023
Investors: Fidelity, OrbiMed and + 3 Other investors